Feasibility of opioid‐free surgery for inflammatory bowel disease

Abstract

AbstractAimPatients undergoing colorectal surgery or those with inflammatory bowel disease (IBD) are particularly at risk for opioid‐related complications and progression to long‐term opioid dependence. The aim of this work is to explore the real‐world possibility of perioperative opioid avoidance in colorectal surgery and IBD.MethodWe conducted a retrospective analysis of patients aggregated from two prospective studies on multimodal postoperative pain control conducted at a single tertiary referral centre. All patients underwent major colorectal surgery with bowel resection. Patients with chronic preoperative opioid use were excluded. Opioid use was measured in oral morphine equivalents (OME) each postoperative day (POD) and cumulatively for the first 72 h.ResultsOur cohort of 209 patients included 148 (71%) with IBD and 61 (29%) non‐IBD patients. IBD patients required significantly more opioids cumulatively over the first 72 postoperative hours compared with non‐IBD patients [median OME 77 mg (interquartile range 33–148 mg) vs. 4 mg (interquartile range 17–82 mg), respectively; p = 0.001]. Five percent of IBD patients achieved opioid‐free postoperative pain control during the entire 72 h postoperative period compared with 12% of non‐IBD patients. Only 7% of IBD patients avoided opioid use on POD 1 compared with 20% of non‐IBD patients (p = 0.02); however the number of IBD patients increased to 16% on POD 2 then 40% on POD 3, closely resembling the non‐IBD cohort at 49% (p = 0.22).ConclusionIn the era of modern enhanced recovery protocols and minimally invasive techniques, we show that early postoperative opioid avoidance is feasible in a limited number of IBD patients after colorectal surgery.